| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $227.0M | -9.7% |
| R&D Expense | $424.1M | -27.0% |
| SG&A Expense | $246.2M | -36.1% |
| Operating Income | -$559.8M | +35.2% |
| Pre-tax Income | -$547.5M | +38.7% |
| Income Tax | -$479K | -574.6% |
| Net Income | -$547.0M | +38.7% |
| EPS (Basic) | -$10.54 | -2191.3% |
| EPS (Diluted) | -$10.54 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $561.6M | -40.5% |
| Accounts Receivable | $21.9M | +27.4% |
| Current Assets | $602.7M | -39.8% |
| Total Assets | $1.38B | -17.3% |
| Current Liabilities | $107.3M | -34.5% |
| Total Liabilities | $661.4M | +16.4% |
| Stockholders' Equity | $716.1M | -34.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$319.6M | -8.2% |
| Capital Expenditures | $62.5M | +53.3% |
| Investing Cash Flow | -$62.2M | +22.9% |
| Financing Cash Flow | -$1.7M | +45.9% |
| Free Cash Flow | -$382.1M | -13.6% |
| -2191.3% |